Skip to main content
Premium Trial:

Request an Annual Quote

Road to AgSuccess?

Rosetta Green, an Israeli biotech company focused on uncovering genes that can be used to improve agricultural and biofuel crops, has been bought by Monsanto fro $35 million, reports Bioentrepreneur's Trade Secrets blog. Rosetta Green was a spinoff from Rosetta Genomics.

This, writes Bernard Dichek at Trade Secrets, could be the beginning of a trend.

Another company, Evogene, may be following a similar path, he says. It was created out of Compugen, and now focuses on agbio with "a number of collaborative agreements underway with Monsanto," Dichek writes.

"These two companies might be at the forefront of a wave of successful, ag-biotech Israeli firms," he adds.